Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Red Vine Leaf Extract in Healthy Volunteers
NCT02191241Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2001
- Primary completion
- Sep 2004
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of Red vine leaf extract in chronic venous insufficiency (CVI), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum Concentration at 24 hours and Area Under the Curve extrapolated to infinity at 24 hours. Started Aug 2001; status: completed.
02
Drugs
Red vine leaf extract
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT02191241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191241.